This report studies the Atrial Fibrillation Devices market. Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Atrial Fibrillation Devices are the devices used for atrial fibrillation therapy, including access, diagnostic, visualization and ablation products to assist physicians in diagnosing and treating various irregular heart rhythms.
The leading manufacturers of atrial fibrillation devices include St. Jude Medical, Boston Scientific, Biosense Webster, Medtronic, Japan Lifeline, and Atricure, with the top three accounting for about 65%.
North America is the largest market with about 35%, followed by Europe with about 30%.

Market Analysis and Insights: Global Atrial Fibrillation Devices Market
In 2020, the global Atrial Fibrillation Devices market size was US$ 3130.2 million and it is expected to reach US$ 5576.8 million by the end of 2027, with a CAGR of 8.6% during 2021-2027.
Global Atrial Fibrillation Devices Scope and Market Size
Atrial Fibrillation Devices market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Atrial Fibrillation Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Atrial Fibrillation Devices market is segmented into
Catheter Ablation
Maze Surgery

Segment by Application, the Atrial Fibrillation Devices market is segmented into
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape and Atrial Fibrillation Devices Market Share Analysis
Atrial Fibrillation Devices market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Atrial Fibrillation Devices product introduction, recent developments, Atrial Fibrillation Devices sales by region, type, application and by sales channel.

The major companies include:
Abbott
Boston Scientific
Biosense Webster
Medtronic
Japan Lifeline
AtriCure
Biotronik
Philips
Synaptic Medical
Osypka AG
MicroPort Scientific
CardioFocus
Lepu Medical
APT Med
TZ Medical